A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD.
Juthaporn CowanSunita MulpuruSara J AbdallahAnchal ChopraAndrew PurssellMichaeline McGuintyGonzalo G AlvarezAntonio GiuliviVicente Corrales-MedinaDerek MacFaddenLoree BoyleDelvina HasimjaKednapa ThavornRanjeeta MallickShawn D AaronD William CameronPublished in: International journal of chronic obstructive pulmonary disease (2021)
NCT0290038, registered 24 February 2016, https://clinicaltrials.gov/ct2/show/NCT02690038 and NCT03018652, registered January 12, 2017, https://clinicaltrials.gov/ct2/show/NCT03018652.
Keyphrases
- phase iii
- chronic obstructive pulmonary disease
- double blind
- image quality
- dual energy
- computed tomography
- clinical trial
- contrast enhanced
- placebo controlled
- study protocol
- phase ii
- liver failure
- cystic fibrosis
- open label
- positron emission tomography
- lung function
- magnetic resonance imaging
- respiratory failure
- randomized controlled trial
- magnetic resonance
- aortic dissection
- replacement therapy
- air pollution